title: [Expectation for new-generation drug eluting stents].
abstract: Drug eluting stent (DES) dramatically reduced the instent restenosis(ISR). However, very late stent thrombosis appeared as another significant problem especially after the termination of dual antiplatelet therapy. The next-generation DESs are characterized by either biodegradable polymer, controlled drug delivery or biodegradable stent. By the introduction of these DESs, it is expected to reduce any long-term sequels while ensuring the reduction of ISR.
authors.affiliation: Cardiology & Catheter Laboratory, Shonan Kamakura General Hospital.
authors.forename: Shigeru
authors.initials: S
authors.lastname: Saito
mesh_terms: D020341:Absorbable Implants; D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D023903:Coronary Restenosis / Q000517:prevention & control; D054855:Drug-Eluting Stents / Q000009:adverse effects / Q000639:trends*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D011108:Polymers; D013927:Thrombosis / Q000209:etiology
chemical_list: D010975:Platelet Aggregation Inhibitors; D011108:Polymers